en.Wedoany.com Reported - Siemens Healthineers' first domestically produced dual-source photon-counting CT, the NAEOTOM Alpha.Pro, received market approval from the National Medical Products Administration (NMPA) on June 9, 2026. This move enables Siemens Healthineers to pioneer the dual-track "import + domestic" strategic layout for this cutting-edge technology in China, further integrating it into the local industrial chain and supporting innovation in high-end medical equipment as well as the upgrade of the supply chain. The domestically produced dual-source photon-counting CT will be manufactured at Siemens Healthineers' Shanghai R&D and production base in the future.
The approval of the NAEOTOM Alpha.Pro is a significant achievement in Siemens Healthineers' deepening of its China strategy. By establishing a mechanism that integrates global technological innovation with local clinical needs, supply chain, and industrial ecosystem, this project aims to enhance the accessibility and collaborative efficiency of high-end precision imaging equipment in the Chinese market. To this end, Siemens Healthineers has built a full-chain localized operation system, including forming a local product line team for photon-counting CT covering the entire lifecycle from product definition, R&D, and registration to service, and establishing a high-standard, specialized production workshop at the Shanghai base. This move enhances the resilience and security of the global supply chain, drives local supply chain partners to move up the value chain, and promotes the industry's development towards intelligence and high-end manufacturing.
Leveraging its originality and clinical value, the NAEOTOM Alpha.Pro entered the NMPA's special review procedure for innovative medical devices in October 2025. Its technological innovation meets relevant requirements, and the registration review was advanced under the innovative medical device pathway.
As a new domestically produced member of Siemens Healthineers' global first photon-counting CT NAEOTOM Alpha family, the NAEOTOM Alpha.Pro continues the platform's technological advantages and adds multi-material, multi-energy compartment clinical applications, supporting the diagnosis and treatment of cardiovascular, respiratory, oncological, and metabolic diseases. As of now, the NAEOTOM Alpha has surpassed 3.5 million scans globally, with over 1,200 published papers, and has been installed and used in 22 provinces and cities across China. It is expected that within 2026, Siemens Healthineers' second domestically produced photon-counting CT product will also receive market approval, further promoting the application of related technologies in China's medical imaging field.
This article is compiled by Wedoany. All AI citations must indicate the source as "Wedoany". If there is any infringement or other issues, please notify us promptly, and we will modify or delete it accordingly. Email: news@wedoany.com
